web analytics

Category: News

2022


07.19

OnSite® COVID-19 Ag Self Test is the first self test to receive WHO Emergency Use Listing

OnSite® COVID-19 Ag Self Test is the first self test to receive WHO Emergency Use Listing

On July 18th 2022, CTK Biotech’s OnSite® COVID-19 Ag Self Test received  WHO Emergency Use Listing for meeting WHO’s quality, safety, and performance requirements. CTK’s COVID-19 Ag Self Test is the first in the market to receive this Pre-Qualification. This milestone accomplishment reflects CTK’s 20-plus years of experience in providing best-in-class products across the globe. Read more about the WHO’s.... Read Full Article >

2021


12.23

CTK Biotech’s Dengue IgG Rapid Test listed by US CDC for testing prior to use of Dengvaxia Dengue vaccine

CTK Biotech’s Dengue IgG Rapid Test listed by US CDC for testing prior to use of Dengvaxia Dengue vaccine

CTK Biotech is proud to announce that the OnSite Dengue IgG Rapid Test is included in the CDC’s two-step testing algorithm for concluding evidence of prior acute dengue virus infection prior to vaccination with Sanofi’s Dengvaxia Dengue vaccine. In the United States, Dengvaxia is available for use in children and adolescents 9–16 years old with laboratory-confirmed previous dengue virus infection.... Read Full Article >

2021


08.12

CTK’s Aridia Real-Time COVID-19 PCR Tests detect new SARS-CoV-2 variants, including U.K., South Africa, Brazil, California, Nigeria, and India/Delta variants

CTK’s goal during the current COVID-19 pandemic is to provide quality diagnostic tools for the detection of SARS-CoV-2, such as the Aridia Real-Time COVID-19 PCR Test. As new SARS-CoV-2 variants are identified, CTK has been working on confirmation studies to ensure that the performance of the Aridia COVID-19 Real-Time PCR Test isn’t affected by these mutations. The Aridia COVID-19 Real-Time.... Read Full Article >

2021


07.09

UPDATE: OnSite Covid-19 Ag Rapid Tests detect new SARS-CoV-2 variants – California, Nigeria, and India/Delta variants

As more and more variants are emerging, CTK’s commitment to ensure that CTK’s OnSite® COVID-19 Ag Rapid Test isn’t affected by these mutations is ongoing. We analyzed the NP mutations present in the California, Nigeria, and India/Delta variants and mapped them on the SARS-CoV-2 NP protein recognized by CTK’s OnSite® COVID-19 Ag Rapid Test using ELISA and peptide scanning. We found that.... Read Full Article >

2020


12.16

Rapid identification and isolation of COVID-19 patients by prescreening VTM samples? The OnSite COVID-19 Ag Rapid Test by CTK might be the answer!

The performance of the OnSite® COVID-19 Ag Rapid Test by CTK was evaluated using sample material from nasopharyngeal swabs stored in viral transport media. The swabs were previously used to screen for SARS-CoV-2 using qPCR.  The OnSite® COVID-19 Ag Rapid Test sensitivity was between 86-90% depending on the viral load*. The study used leftover sample material selected from samples sent.... Read Full Article >

2020


11.13

A Complete COVID-19 Management Solution

CTK is proud to provide a Complete COVID-19 Management Solution with the addition of our COVID-19 Antigen Rapid Test! See below for details!     OnSite  COVID-19 Ag Rapid Test Cat# R0182C Early diagnosis by detecting viral components within 1 week of symptoms High specificity ensures quick isolation of positive individuals Results in 15-20 minutes Doesn’t provide information on immune.... Read Full Article >

2020


08.18

CTK and Employee Safety!

CTK’s vision is to provide quick and accurate solutions for every possible clinical scenario, and we continued to deliver on that mission with the development of our Aridia COVID-19 PCR kit for confirmation and our COVID-19 IgG/IgM Rapid Test for screening. This would not have been possible without the hard work and dedication of our employees. With our same level.... Read Full Article >

2017


03.02

National (U.S.) Colorectal Cancer Awareness

  March is National (U.S.) Colorectal Cancer Awareness month.   This year, Colorectal Cancer Awareness Month comes on the heels of a recent study by the American Cancer Society (ACS) revealing some staggering findings: People born in 1990 have double the risk of colon cancer and quadruple the risk of rectal cancer compared to people in 1950 In 2017, the.... Read Full Article >

2016


10.31

43% of Children Under Five at Risk of Poor Development.What Can We Do?

43% of Children Under Five at Risk of Poor Development. What Can We Do? “An estimated 43 percent—249 million—of children under five in low-and middle-income countries (LMICs) are at an elevated risk of poor development due to extreme poverty and stunting. Lancet – Advancing Early Childhood Development: from Science to Scale Recommendations to help reverse this trend include implementing low-cost.... Read Full Article >

2016


10.01

What is the deadliest animal in the world?

What is the deadliest animal in the world? According to the World Health Organization Mosquitoes — one of the deadliest animals in the world  Their ability to carry and spread the disease to humans causes millions of deaths every year. There are several different types of mosquitoes and some have the ability to carry many different diseases. Can you identify.... Read Full Article >

2016


04.25

Today is World Malaria Day!

World Malaria Day On April 25, 2016 people around the world will participate in World Malaria Day, taking part in events to fight against and raise awareness about malaria. Facts about Malaria1 : 3.2 billion people in 97 countries – nearly half of the world’s population –  are currently at risk for malaria disease transmission Roughly 15 countries – mainly.... Read Full Article >